Sionna Therapeutics Inc [SION] stock is trading at $27.08, up 1.31%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The SION shares have gain 21.87% over the last week, with a monthly amount glided 12.55%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Sionna Therapeutics Inc [NASDAQ: SION] stock has seen the most recent analyst activity on September 03, 2025, when RBC Capital Mkts initiated its Sector Perform rating and assigned the stock a price target of $22. Previously, Raymond James started tracking the stock with Strong Buy rating on September 03, 2025, and set its price target to $45. On March 04, 2025, TD Cowen initiated with a Buy rating. Stifel started tracking the stock assigning a Buy rating and suggested a price target of $32 on March 04, 2025. Guggenheim initiated its recommendation with a Buy and recommended $45 as its price target on March 04, 2025.
Sionna Therapeutics Inc [SION] stock has fluctuated between $7.26 and $27.39 over the past year. Currently, Wall Street analysts expect the stock to reach $33.5 within the next 12 months. Sionna Therapeutics Inc [NASDAQ: SION] shares were valued at $27.08 at the most recent close of the market. An investor can expect a potential return of 23.71% based on the average SION price forecast.
Analyzing the SION fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.17, Equity is -0.63 and Total Capital is -0.21. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 26.06 points at the first support level, and at 25.03 for the second support level. However, for the 1st resistance point, the stock is sitting at 27.80, and for the 2nd resistance point, it is at 28.51.
Ratios To Look Out For
For context, Sionna Therapeutics Inc’s Current Ratio is 35.33. Further, the Quick Ratio stands at 35.33, while the Cash Ratio is 5.43.
Transactions by insiders
Recent insider trading involved Fitzpatrick Jennifer, Chief Legal Officer, that happened on Sep 04 ’25 when 10250.0 shares were sold. Officer, JENNIFER R FITZPATRICK completed a deal on Sep 04 ’25 to buy 10250.0 shares. Meanwhile, CFO & Head of Corp. Dev. Ridloff Elena sold 8836.0 shares on Sep 02 ’25.
